A detailed history of Whittier Trust CO transactions in Bio N Tech Se stock. As of the latest transaction made, Whittier Trust CO holds 52 shares of BNTX stock, worth $5,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52
Previous 52 -0.0%
Holding current value
$5,185
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 24, 2023

SELL
$102.58 - $129.66 $8,719 - $11,021
-85 Reduced 62.04%
52 $5,000
Q1 2023

Apr 21, 2023

BUY
$122.57 - $153.67 $4,657 - $5,839
38 Added 38.38%
137 $17,000
Q4 2022

Jan 25, 2023

BUY
$118.43 - $186.05 $1,658 - $2,604
14 Added 16.47%
99 $0
Q1 2022

Apr 29, 2022

BUY
$126.25 - $231.85 $10,731 - $19,707
85 New
85 $14,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.